Tarsa adds $28 million in series B

Tarsa Therapeutics Inc. (Philadelphia, Pa.) raised $28 million in a series B round led by new investor Foresite Capital. Existing investors Novo A/S; MVM Life Science Partners; and Quaker Partners par...